[ Price : $8.95]
CDER approves 50 novel products in 2024, five less than the 55 products approved in 2023 and well above the 10-year rolling annual...[ Price : $8.95]
FDA alerts patients, caregivers, and healthcare providers to the potential for some Boston Scientific Accolade pacemakers to need ...[ Price : $8.95]
FDA approves Xcoverys Ensacove, an anaplastic lymphoma kinase inhibitor, to treat some non-small cell lung cancers.[ Price : $8.95]
FDA approves Humacytes Symvess for use with some extremity arterial injuries.[ Price : $8.95]
FDA recommends that companies making transmucosal buprenorphine drugs indicated to treat opioid dependence revise the labeling to ...[ Price : $8.95]
FDA publishes an updated Global Unique Device Identification Database guidance.[ Price : $8.95]
FDA approves Novo Nordisks Alhemo as a prophylaxis for some hemophilia patients.[ Price : $8.95]
FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.